Regulatory mandates are the primary catalyst for the Pharmaceutical Isolator Market. The revised EU GMP Annex 1, enforced in August 2023, mandates contamination control strategies for all sterile manufacturing facilities, driving an estimated USD 2.8 billion in cleanroom and isolator retrofit spending through 2028. The FDA's updated cGMP guidance similarly reinforces preference for closed...